205 related articles for article (PubMed ID: 19741566)
1. CYP2D6: novel genomic structures and alleles.
Kramer WE; Walker DL; O'Kane DJ; Mrazek DA; Fisher PK; Dukek BA; Bruflat JK; Black JL
Pharmacogenet Genomics; 2009 Oct; 19(10):813-22. PubMed ID: 19741566
[TBL] [Abstract][Full Text] [Related]
2. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
[TBL] [Abstract][Full Text] [Related]
3. Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
Black JL; Walker DL; O'Kane DJ; Harmandayan M
Drug Metab Dispos; 2012 Jan; 40(1):111-9. PubMed ID: 22004686
[TBL] [Abstract][Full Text] [Related]
4. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
[TBL] [Abstract][Full Text] [Related]
5. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.
Gaedigk A; Twist GP; Leeder JS
Pharmacogenomics; 2012 Jan; 13(1):91-111. PubMed ID: 22111604
[TBL] [Abstract][Full Text] [Related]
8. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
9. Nanopore sequencing of the pharmacogene
Liau Y; Maggo S; Miller AL; Pearson JF; Kennedy MA; Cree SL
Pharmacogenomics; 2019 Sep; 20(14):1033-1047. PubMed ID: 31559921
[No Abstract] [Full Text] [Related]
10. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes.
Lundqvist E; Johansson I; Ingelman-Sundberg M
Gene; 1999 Jan; 226(2):327-38. PubMed ID: 9931507
[TBL] [Abstract][Full Text] [Related]
11. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population.
Menoyo A; del Rio E; Baiget M
Cell Biochem Funct; 2006; 24(5):381-5. PubMed ID: 16130179
[TBL] [Abstract][Full Text] [Related]
12. The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements.
Gaedigk A; Coetsee C
Eur J Clin Pharmacol; 2008 May; 64(5):465-75. PubMed ID: 18202841
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.
Gaedigk A; Ndjountché L; Divakaran K; Dianne Bradford L; Zineh I; Oberlander TF; Brousseau DC; McCarver DG; Johnson JA; Alander SW; Wayne Riggs K; Steven Leeder J
Clin Pharmacol Ther; 2007 Feb; 81(2):242-51. PubMed ID: 17259947
[TBL] [Abstract][Full Text] [Related]
15. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yang Y; Botton MR; Scott ER; Scott SA
Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112
[TBL] [Abstract][Full Text] [Related]
16. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.
Daly AK; Fairbrother KS; Andreassen OA; London SJ; Idle JR; Steen VM
Pharmacogenetics; 1996 Aug; 6(4):319-28. PubMed ID: 8873218
[TBL] [Abstract][Full Text] [Related]
17. Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection.
Qiao W; Martis S; Mendiratta G; Shi L; Botton MR; Yang Y; Gaedigk A; Vijzelaar R; Edelmann L; Kornreich R; Desnick RJ; Scott SA
Pharmacogenomics; 2019 Jan; 20(1):9-20. PubMed ID: 30730286
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR.
Hersberger M; Marti-Jaun J; Rentsch K; Hänseler E
Clin Chem; 2000 Aug; 46(8 Pt 1):1072-7. PubMed ID: 10926885
[TBL] [Abstract][Full Text] [Related]
19. Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication.
Ledesma MC; Agúndez JA
Clin Chem; 2005 Jun; 51(6):939-43. PubMed ID: 15817819
[TBL] [Abstract][Full Text] [Related]
20. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
